ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "anti-CCP antibodies and anti-citrullinated protein/peptide antibodies (ACPA)"

  • Abstract Number: 2668 • ACR/ARHP Annual Meeting 2015

    Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate

    T. W. J. Huizinga1, SE Connolly2, A Johnsen2, J Zhu2, Daniel E. Furst3, VP Bykerk4, Gerd Burmester5, BG Combe6, DA Wong2, LA Trouw1, René E. M. Toes1 and Paul Emery7, 1Leiden University Medical Center, Leiden, Netherlands, 2Bristol-Myers Squibb, Princeton, NJ, 3Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 4Weill Cornell Medical College, New York, NY, 5Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, 6Montpellier University, Montpellier, France, 7University of Leeds, Leeds, United Kingdom

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are a marker of RA, and the presence of the immunoglobulin M (IgM) isotype indicates an ongoing immune response involving…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology